ADIPOQ and idiopathic pulmonary fibrosis: Adiponectin inhibited the stiffness-induced activation of lung fibroblasts across the entire range of matrix stiffnesses reported from patients with IPF, inhibiting expression of profibrotic markers on the transcript (Fig. 3, A and B) and protein level (Fig. 3C).